Dignam named as new RTOG group statistician

Justine Varieur Cadet | | Health Imaging | Oncology Imaging
James J. Dignam, PhD, has been named the new group statistician for the Radiation Therapy Oncology Group (RTOG) and will lead the efforts of RTOG's Statistics and Data Management Center. 

Dignam is an associate professor of biostatistics in the department of health studies at the University of Chicago and is an investigator at the University of Chicago Cancer Research Center. He has cancer clinical trial research background, having been a statistician for both the National Surgical Adjuvant Breast and Bowel Project and the American College of Surgeons Oncology Group (ACoSOG), in addition to his current work with the University of Chicago.

RTOG is a National Cancer Institute (NCI)-funded national clinical trials group and is administered by the American College of Radiology (ACR).

Justine Varieur Cadet

Related Content

Imaging may be misleading when determining the success of cancer treatment
Prostate cancer radiotherapy timeline can be safely shortened
New radiopharmaceutical targeted at gastrointenstinal cancers yields impressive results
New PET method combines antibody with radioactive isotope to improve lung cancer detection
VI-RADS threshold, imaging features predict bladder cancer invasiveness with nearly 100% accuracy
PHOTO GALLERY: thyroid nodule imaging

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.